Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA

Simple, Portable, Gas Flow Analyzer Provides Immediate Results

By BiotechDaily International staff writers
Posted on 13 Feb 2013
 Image: the VT305 gas flow analyzer (Photo courtesy of Fluke Biochemical).
Image: the VT305 gas flow analyzer (Photo courtesy of Fluke Biochemical).
A new gas flow analyzer is a small lightweight instrument, simple to use, and engineered for efficiency.

An intuitive four-button control panel, auto-orienting color LCD screen, and single flow channel are the reason for the simplicity of the VT305. Additionally, the VT305 provides instant readable graphs, which can be saved or transferred using an SD [secure digital] card. The automation provided by the Ansur Test Automation software helps reduce human error, improves data consistency, and ensures compliance with original equipment manufacturer (OEM) requirements. In addition, the VT305 tests ventilators and all other gas flow and pressure-producing devices including anesthesia machines, insufflators, suction devices, pressure gauges, flow meters, etc. The VT305 Gas Flow Analyzer is the efficient, versatile choice for biomeds looking to complete their test and measurement fleet.

Designed for the highly mobile biomed or service engineer, the VT305 Gas Flow Analyzer features internal sensors making connecting to medical devices a fast and easy process, explained Jerry Zion, product manager for Fluke Biomedical (Everett, WA, USA) the company that produces the instrument. He added, "No additional parts are required and the VT305 fits in your hand. You can get instant results in three simple steps. The VT305 will be the portable test tool of choice for highly mobile users."

Related Links:

Fluke Biomedical



Channels

Genomics/Proteomics

view channel
Image: Cancer cells, left, were pretreated with a drug that blocks the ERK signal, and right, without the pretreatment. Top cells are untreated, while the bottom ones are stimulated (Photo courtesy of the Weizmann Institute of Science).

Prevention of ERK Nuclear Translocation Blocks Cancer Proliferation in Animal Models

A team of cell biologists has shown that the cancer promoting effects of ERK dysregulation can be blocked by low molecular weight drugs that prevent translocation of this kinase from the cells' cytoplasm... Read more

Drug Discovery

view channel
Image: Star-like glial cells in red surround alpha-beta plaques in the cortex of a mouse with a model of Alzheimer\'s disease (Photo courtesy of Strittmatter laboratory/Yale University).

Experimental Cancer Drug Reverses Symptoms in Mouse Model of Alzheimer's Disease

An experimental, but clinically disappointing drug for treatment of cancer has been found to be extremely effective in reversing the symptoms of Alzheimer's disease (AD) in a mouse model.... Read more

Biochemistry

view channel
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead... Read more

Business

view channel

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center (Houston, TX, USA) and NanoString Technologies, Inc. (Seattle, WA, USA) will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology... Read more
 

Events

21 Apr 2015 - 23 Apr 2015
21 Apr 2015 - 23 Apr 2015
Copyright © 2000-2015 Globetech Media. All rights reserved.